These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 15068837

  • 41. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
    Maier TJ, Schilling K, Schmidt R, Geisslinger G, Grösch S.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1469-78. PubMed ID: 15041464
    [Abstract] [Full Text] [Related]

  • 42. COX-2 inhibitors: new drugs for the management of pain and inflammation.
    Hutchins V, Hutchins B.
    Dent Today; 2001 Feb 15; 20(2):56-61. PubMed ID: 12524847
    [No Abstract] [Full Text] [Related]

  • 43. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
    Pruthi RS, Derksen E, Gaston K.
    J Urol; 2003 Jun 15; 169(6):2352-9. PubMed ID: 12771797
    [Abstract] [Full Text] [Related]

  • 44. Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention.
    Vanchieri C.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):552-3. PubMed ID: 15840872
    [No Abstract] [Full Text] [Related]

  • 45. Clinical pharmacology of selective COX-2 inhibitors.
    Capone ML, Tacconelli S, Sciulli MG, Patrignani P.
    Int J Immunopathol Pharmacol; 2003 Apr 20; 16(2 Suppl):49-58. PubMed ID: 14552704
    [Abstract] [Full Text] [Related]

  • 46. Cyclooxygenase-2: from arthritis treatment to new indications for the prevention and treatment of cancer.
    Yamamoto DS, Viale PH.
    Clin J Oncol Nurs; 2003 Apr 20; 7(1):21-9. PubMed ID: 12629931
    [Abstract] [Full Text] [Related]

  • 47. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
    Wolfe F, Michaud K, Burke TA, Zhao SZ.
    J Rheumatol; 2004 Feb 20; 31(2):355-8. PubMed ID: 14760808
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Role of cyclooxygenase-1 and -2 in health and disease.
    Lipsky PE.
    Am J Orthop (Belle Mead NJ); 1999 Mar 20; 28(3 Suppl):8-12. PubMed ID: 10193997
    [Abstract] [Full Text] [Related]

  • 51. Role of COX-2 selective inhibitors for prevention and treatment of cancer.
    Amir M, Agarwal HK.
    Pharmazie; 2005 Aug 20; 60(8):563-70. PubMed ID: 16124396
    [Abstract] [Full Text] [Related]

  • 52. Successful use of cyclooxygenase-2 inhibitor in a patient with aspirin-induced asthma.
    Marks F, Harrell K, Fischer R.
    South Med J; 2001 Feb 20; 94(2):256-7. PubMed ID: 11235048
    [Abstract] [Full Text] [Related]

  • 53. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.
    Reddy BS, Rao CV.
    J Environ Pathol Toxicol Oncol; 2002 Feb 20; 21(2):155-64. PubMed ID: 12086402
    [Abstract] [Full Text] [Related]

  • 54. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.
    Kashfi K, Rigas B.
    Biochem Pharmacol; 2005 Oct 01; 70(7):969-86. PubMed ID: 15949789
    [Abstract] [Full Text] [Related]

  • 55. An update on specific COX-2 inhibitors: the COXIBs.
    Gupta S, Crofford LJ.
    Bull Rheum Dis; 2001 Oct 01; 50(1):1-4. PubMed ID: 12092091
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. COX-2 inhibition as a tool to treat and prevent colorectal cancer.
    Tuynman JB, Peppelenbosch MP, Richel DJ.
    Crit Rev Oncol Hematol; 2004 Nov 01; 52(2):81-101. PubMed ID: 15501074
    [Abstract] [Full Text] [Related]

  • 58. Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?
    Sanborn R, Blanke CD.
    Semin Oncol; 2005 Feb 01; 32(1):69-75. PubMed ID: 15726508
    [Abstract] [Full Text] [Related]

  • 59. [Adverse effect-free analgesia. New COX-2 inhibitor is even more selective].
    MMW Fortschr Med; 2003 May 01; 145(18):54. PubMed ID: 12808824
    [No Abstract] [Full Text] [Related]

  • 60. Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.
    Zeytin HE, Patel AC, Rogers CJ, Canter D, Hursting SD, Schlom J, Greiner JW.
    Cancer Res; 2004 May 15; 64(10):3668-78. PubMed ID: 15150127
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.